Skip to main content
SpringerLink
Log in
Book cover

Ovarian Cancer pp 23–35Cite as

Recent advances in the immunodiagnosis of epithelial ovarian carcinoma

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 23))

Abstract

Since we last reviewed the immunology of ovarian carcinoma for this series [1], there have been several advances in the development of serum markers for epithelial ovarian cancer. Much of this progress has related to the identification of tumor associated antigens using the monoclonal technology [2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bast RC Jr, Knapp RC: The immunobiology of ovarian carcinoma. In: Gynecologic Oncology, Griffiths CT, Fuller AF (eds). Boston: Martinus Nijhoff Publishers, 1983, pp 187–226.

    Google Scholar 

  2. Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497, 1975.

    Article  PubMed  CAS  Google Scholar 

  3. Bast RC Jr, Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:1331–1337, 1981.

    Article  PubMed  Google Scholar 

  4. Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC, Colvin RB: Tissue distribution of a coelomic epithelium related antigen recognized by the monoclonal antibody OC 125. Int J Gyn Path 2:275–285, 1983.

    Article  CAS  Google Scholar 

  5. Kabawat SE, Bast RC Jr, Welch WR, Knapp RC, Colvin RB: Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid and clear cell types. Am J Clin Path 79:98–104, 1983.

    PubMed  CAS  Google Scholar 

  6. Buick RN, Pullano R, Knapp RC, Urbach GI, Chang PL, Bast RC Jr: Classification of ovarian tumor associated antigens on the basis of distribution on cell populations undergoing differentiation. Proc Amer Assoc Cancer Res 25:40, (abstr), 1984.

    Google Scholar 

  7. Masuho Y, Zalutsky M, Knapp RC, Bast RC Jr: Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas. Cancer Res, 44:2813–2819, 1984.

    PubMed  CAS  Google Scholar 

  8. Bast RC Jr, Klug TL, St. John E, Jenison E, Niloff J, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–887, 1983.

    Article  PubMed  Google Scholar 

  9. Klug TL, Bast RC Jr, Niloff JM, Knapp RC, Zurawski VR Jr: Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res 44:1048–1053, 1984.

    PubMed  CAS  Google Scholar 

  10. Bast RC Jr, Klug TL, Schaetzl E, Lavin P, Niloff J, Greber TF, Zurawski VR Jr, Knapp RC: Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9 and carcinoembryonic antigen, Am J Obstet Gynecol, 149:553–559, 1984.

    PubMed  Google Scholar 

  11. Chatal JF, Ricolleau G, Fumoleau P, Kramer M, Curtet C, Douillard JY: Radioimmunoassay of the CA 12-5 antigen in epithelial ovarian carcinomas. Cancer Detection Prevention 6:624, 1983.

    Google Scholar 

  12. Crombach G, Zippel HH, Wurz H: Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer. Cancer Detection Prevention 6:623, 1983.

    Google Scholar 

  13. Kreienberg R, Melchart: CA 125-A new radioimmunoassay for monitoring patients with epithelial ovarian carcinoma. Cancer Detection Prevention 6:619, 1983.

    Google Scholar 

  14. Niloff JM, Klug TL, Schaetzl E, Zurawski VR Jr, Knapp RC, Bast RC JR: Elevation of serum CA 125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol, 148:1057–1058, 1984.

    PubMed  CAS  Google Scholar 

  15. Bast RC Jr, Siegal EP, Runowicz C, Klug TL, Zurawski VR Jr, Schonoholz D, Cohen CJ, Knapp RC: Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma. Gynecol Oncol, in press.

    Google Scholar 

  16. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC Jr: Ca 125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol, in press.

    Google Scholar 

  17. Ruibal A, Encabo G, Miralles EM, Domenech FM: CA 125 seric levels in non ovarian pathologies. Med Clin (Barcelona) 82:500–501, 1984.

    Google Scholar 

  18. Bhattacharya M, Chatterjee SK, Barlow JJ, Fuji H: Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas. Cancer Res 42:1650–1654, 1982.

    PubMed  CAS  Google Scholar 

  19. Colnaghi MI, Canaveri S, Dellatorre G, et al.: Monoclonal antibodies directed against human tumors. Proc 13th Int Cancer Congress P. 55, 1982.

    Google Scholar 

  20. Berkowitz RS, Kabawat S, Lazarus H, Colvin RC, Knapp RC, Bast RC Jr: Comparison of a rabbit heteroantiserum and a murine monoclonal antibody raised against a human epithelial ovarian carcinoma cell line. Am J Obstet Gynecol 146:607–612, 1983.

    PubMed  CAS  Google Scholar 

  21. Mattes MJ, Cordon-Cardo C, Lewis JC Jr, et al.: Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies. Proc Natl Acad Sci (USA), in press.

    Google Scholar 

  22. Metzgar RS, Gaillard MT, Levske JJ, et al.: Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res 42:601–608, 1982.

    PubMed  CAS  Google Scholar 

  23. Metzgar RS, Rodriguez BS, Daasch VN, Fernsten PD, Meyers WC, Sindelar WF, Sandler RS, Seigler HF: Competition radioimmune assay for detection of a pancreatic cancer associated antigen (DU-PAN-2) in serum and ascited of patients with adenocarcinoma. Proc Natl Acad Sci (USA), in press.

    Google Scholar 

  24. Daasch VN, Fernsten PD, Metzgar RS: Radioimmunoassay studies of a monoclonal antibody to detect antigen (DUPAN-2) in the serum or ascites of adenocarcinoma patients. Proc Amer Assoc Cancer Res 23:266, 1982.

    Google Scholar 

  25. Papsidero LD, Croghan GA, O’Connell MJ, Valenzuela LA, Nemoto T, Chu TM: Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma. Cancer Res 43:1741–1747, 1983.

    PubMed  CAS  Google Scholar 

  26. Croghan GA, Papsidero LD, Valenzuela LA, Nemoto T, Penetrante R, Chu TM: Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22. Cancer Res 43:4980–4988, 1983.

    PubMed  CAS  Google Scholar 

  27. Croghan GA, Wingate MB, Gamarra M, Johnson E, Chu TM, Allen H, Valenzuela L, Tsukada Y, Papsidero D: Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas. Cancer Res 44:1954–1962, 1984.

    PubMed  CAS  Google Scholar 

  28. Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer JP: Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 5:957–972, 1979.

    Article  PubMed  CAS  Google Scholar 

  29. Magnani JL, Steplewski Z, Koprowski H, Ginsburg V: Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 43:5489–5492, 1983.

    PubMed  CAS  Google Scholar 

  30. Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski VR Jr: Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clinical Chem. 29/3:549–552, 1983.

    Google Scholar 

  31. Herlyn M, Sears HF, Steplewski Z, Koprowski H: Monoclonal antibody detection of a circulating tumor-associated antigen I. Presence of antigen in sera of patients with colorectal, gastric and pancreatic carcinoma. J Clin Immunol 2:135–140, 1982.

    Article  PubMed  CAS  Google Scholar 

  32. Charpin C, Bhan AK, Zurawski VR Jr, Scully RE: Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: An immunohistochemical study with the use of monoclonal antibodies. Int J Gynecol Path 1:231–245, 1982.

    Article  CAS  Google Scholar 

  33. Bast RC Jr, Klug T, Knapp RC, Zurawski VR Jr: CA 125 and CA 19-9 can be expressed on the same mucin-like glycoprotein. Submitted for publication.

    Google Scholar 

  34. Chatterjee SK, Bhattacharya M, Barlow J: Glycosyltransferase and glycosidase activities in ovarian cancer patients. Cancer Res 39:1943–1951, 1979.

    PubMed  CAS  Google Scholar 

  35. Waalkes TP, Rosenshein NB, Shaper JH, Ettinger DS, Woo KB, Paone JF, Gehrke CW: A feasibility study in the development of biological markers for ovarian cancer. J. Surgical Onc 21:207–214, 1982.

    Article  CAS  Google Scholar 

  36. Gauduchon P, Tillier C, Guyonnet C, Heron JF, Bar-Guilloux E, Talaer JY: Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma. Cancer Res 43:4491–4496, 1983.

    PubMed  CAS  Google Scholar 

  37. Chatterjee SK, Chowdhury K, Bhattacharya M, Barlow J: Beta-hexosaminidase activities and isoenzymes in normal human ovary and ovarian adenocarcinoma. Cancer 49:128–135, 1982.

    Article  PubMed  CAS  Google Scholar 

  38. Barlow JJ, DiCioccio RA, Dillard PH, Blumenson LE, Matta KL: Frequency of an allele for low activity of -L-Fucosidase in sera: Possible increase in epithelial ovarian cancer patients. JNCI 67:1005–1009, 1981.

    PubMed  CAS  Google Scholar 

  39. Barlow JJ, Dillard PH: Serum protein-bound fucose in patients with gynecologic cancers. Obstet Gynecol 39:727–733, 1972.

    PubMed  CAS  Google Scholar 

  40. Atkin NB, Baker MC, Robinson R, Gaze SE: Chromosome studies on 14 near-diploid carcinomas of the ovary. Eur J Cancer 10:143–146, 1972.

    Google Scholar 

  41. Kakati S, Hayata I, Oshimure M, Sandberg AA: Chromosomes and causation of human cancer and leukemia. X. banding patterns in cancerous effusions. Cancer 35:1729–1738, 1975.

    Article  Google Scholar 

  42. Trent JM, Salmon SE: Karyotypic analysis of human ovarian carcinoma cells cloned in agar. Am J Human Genet 31:379 (abstr), 1979.

    Google Scholar 

  43. Whang-Peng J, Knutsen T, Douglass EC, Chu E, Ozols RF, Hogan WM, Young RC: Cytogenetic studies in ovarian cancer. Cancer Genetics and Cytogenetics 11:91–106, 1984.

    Article  PubMed  CAS  Google Scholar 

  44. Feig L, Bast RC Jr, Knapp RC, Cooper GM: Somatic activation of rask gene in a human ovarian carcinoma. Science 223:698–701, 1984.

    Article  PubMed  CAS  Google Scholar 

  45. Slamon DJ, deKernoin J, Verma IM, Cline M: Expression of cellular oncogenes in human malignancies. Science 224:256–252, 1984.

    Article  PubMed  CAS  Google Scholar 

  46. Knauf S, Urbach GI: A study of ovarian cancer patients using a radioimmunoassay for human ovarian tumor associated antigen OCA.Am J Obstet Gynecol 138:1222, 1223, 1980.

    PubMed  CAS  Google Scholar 

  47. Bhattacharya M, Barlow JJ: Ovarian cystadenocarcinoma-associated antigen (OCAA). In: Compendium of Assays for Immunodiagnosis of Human Cancer. Herberman RB (ed). Amsterdam: Elsevier, North Holland Inc, pp 527–431, 1979.

    Google Scholar 

  48. Knauf S, Urbach GI: Identification, purification and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen. Cancer Res 41:1351–1357, 1981.

    PubMed  CAS  Google Scholar 

  49. Chang P-L, Urbach GI, Dembo AJ: Circulating levels of ovarian cancer antigen NB/70K: Clinical correlations. Proc Amer Soc Clin Oncol 3:2, 1984.

    Google Scholar 

  50. Knauf S, Taillon-Miller P, Helmkamp F, Bonfiglio TA, Beecham JB: Selectivity for ovarian cancer of an improved serum radioimmunoassay for human ovarian tumor-associated antigen NB/70K. Gynecologic Oncol 17:349–355, 1984.

    Article  CAS  Google Scholar 

  51. Woods JC, Sprigas AI, Harris H, McGee JO’D: A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca-1 antibody. Lancet 2:512–514, 1982.

    Article  PubMed  CAS  Google Scholar 

  52. Epenetos AA, Canti G, Taylor-Papadimitriou J, Curling M, Bodmer WF: Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet 2:1004–1006, 1982.

    Article  PubMed  CAS  Google Scholar 

  53. Bramwell ME, Bhavanadant VP, Wiseman G, Harris H: Structure and function of the Ca antigen. Br J Cancer 48:177–183, 1983.

    Article  PubMed  CAS  Google Scholar 

  54. Van Nagell JR Jr, Kim E, Casper S, et al.: Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen. Cancer Res 40:502–506, 1980.

    PubMed  Google Scholar 

  55. Epenetos AA, Britton KE, Mather S, Shepherd J, Granowska M, Taylor-Papadimitriou J, Nimmon CC, Durbin H, Hawkins LR, Malpas JS: Targeting of iodine-123 labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet 2:999–1004, 1982.

    Article  PubMed  CAS  Google Scholar 

  56. Shephard JH, Epenetos AA, Britton KE, et al.: Radioimmune diagnosis of ovarian carcinoma using tumor associated monoclonal antibodies. Proc Soc Gyn Oncol 14:12, 1983.

    Google Scholar 

Download references

Authors
  1. Robert C. Bast Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert C. Knapp
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine Section of Hematology & Oncology, University of Arizona Health Sciences Center, Tucson, Arizona, USA

    David S. Alberts

  2. Department of Obstetrics & Gynecology, University of Arizona Health Sciences Center, Tucson, Arizona, USA

    Earl A. Surwit

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Bast, R.C., Knapp, R.C. (1985). Recent advances in the immunodiagnosis of epithelial ovarian carcinoma. In: Alberts, D.S., Surwit, E.A. (eds) Ovarian Cancer. Cancer Treatment and Research, vol 23. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2561-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2561-1_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9609-6

  • Online ISBN: 978-1-4613-2561-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation